China Medical System Holdings Limited
CHSYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,468,990 | $8,013,285 | $9,150,347 | $8,337,221 |
| % Growth | -6.8% | -12.4% | 9.8% | – |
| Cost of Goods Sold | $2,046,796 | $1,937,334 | $2,114,500 | $2,090,283 |
| Gross Profit | $5,422,194 | $6,075,951 | $7,035,847 | $6,246,938 |
| % Margin | 72.6% | 75.8% | 76.9% | 74.9% |
| R&D Expenses | $329,982 | $195,134 | $125,431 | $114,761 |
| G&A Expenses | $780,093 | $656,628 | $636,612 | $440,995 |
| SG&A Expenses | $3,441,741 | $3,167,969 | $3,357,924 | $2,981,142 |
| Sales & Mktg Exp. | $2,661,648 | $2,511,341 | $2,721,312 | $2,540,147 |
| Other Operating Expenses | -$82,043 | $0 | -$93,063 | -$65,094 |
| Operating Expenses | $3,689,680 | $3,363,103 | $3,390,292 | $3,030,809 |
| Operating Income | $1,732,514 | $2,712,848 | $3,552,492 | $3,151,035 |
| % Margin | 23.2% | 33.9% | 38.8% | 37.8% |
| Other Income/Exp. Net | $277,793 | $160,923 | $210,358 | $305,554 |
| Pre-Tax Income | $2,010,307 | $2,873,771 | $3,762,850 | $3,456,589 |
| Tax Expense | $397,227 | $489,341 | $486,655 | $431,325 |
| Net Income | $1,619,788 | $2,400,940 | $3,258,992 | $3,017,402 |
| % Margin | 21.7% | 30% | 35.6% | 36.2% |
| EPS | 0.67 | 0.98 | 1.33 | 1.22 |
| % Growth | -31.6% | -26.3% | 9% | – |
| EPS Diluted | 0.67 | 0.98 | 1.33 | 1.22 |
| Weighted Avg Shares Out | 2,427,382 | 2,451,989 | 2,453,940 | 2,467,697 |
| Weighted Avg Shares Out Dil | 2,427,382 | 2,451,989 | 2,453,940 | 2,467,697 |
| Supplemental Information | – | – | – | – |
| Interest Income | $126,344 | $146,475 | $105,515 | $81,853 |
| Interest Expense | $38,610 | $46,251 | $49,086 | $28,270 |
| Depreciation & Amortization | $259,238 | $209,301 | $209,079 | $219,820 |
| EBITDA | $2,308,155 | $2,922,149 | $3,761,571 | $3,704,679 |
| % Margin | 30.9% | 36.5% | 41.1% | 44.4% |